Canada · Health Canada Drug Product Database

MESALAZINE

Source ingredient · 30 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

Canada · Source reference 83673

5-ASA

Tablet (Enteric-Coated) / SANIS HEALTH INC

Canada · Source reference 14552

ASACOL

Tablet (Enteric-Coated) / ALLERGAN INC

Canada · Source reference 75261

ASACOL 800

Tablet (Delayed-Release) / ALLERGAN INC

Canada · Source reference 104108

MESALAMINE

Tablet (Delayed-Release) / TILLOTTS PHARMA AG

Canada · Source reference 15218

MESASAL

Tablet (Enteric-Coated) / GLAXOSMITHKLINE INC

Canada · Source reference 78289

MEZAVANT

Tablet (Delayed- And Extended-Release) / TAKEDA CANADA INC

Canada · Source reference 101350

MEZERA

Tablet (Delayed-Release) / AVIR PHARMA INC.

Canada · Source reference 103363

MEZERA

Tablet (Delayed-Release) / AVIR PHARMA INC.

Canada · Source reference 96402

MEZERA

Suppository / AVIR PHARMA INC.

Canada · Source reference 96403

MEZERA

Foam / AVIR PHARMA INC.

Canada · Source reference 83342

NTP-5-AMINOSALICYLIC ACID

Tablet (Enteric-Coated) / TEVA CANADA LIMITED

Canada · Source reference 101886

OCTASA

Tablet (Delayed-Release) / TILLOTTS PHARMA AG

Canada · Source reference 95399

OCTASA

Tablet (Delayed-Release) / TILLOTTS PHARMA AG

Canada · Source reference 75074

PENDO-5 ASA

Tablet (Enteric-Coated) / PENDOPHARM DIVISION OF PHARMASCIENCE INC

Canada · Source reference 16855

PENTASA

Tablet (Extended-Release) / FERRING INC

Canada · Source reference 18493

PENTASA

Suppository / FERRING INC

Canada · Source reference 18494

PENTASA

Suspension / FERRING INC

Canada · Source reference 18496

PENTASA

Suspension / FERRING INC

Canada · Source reference 88434

PENTASA

Tablet (Extended-Release) / FERRING INC

Canada · Source reference 18495

PENTASA ENEMA 2G/100ML

Enema; Liquid / FERRING INC

Canada · Source reference 17853

PENTASA EXTENDED-RELEASE TABLETS 250MG

Tablet (Extended-Release) / FERRING INC

Canada · Source reference 18212

SALOFALK

Suppository / ABBVIE CORPORATION

Canada · Source reference 18214

SALOFALK

Tablet (Delayed-Release) / ABBVIE CORPORATION

Canada · Source reference 18509

SALOFALK

Suspension / ABBVIE CORPORATION

Canada · Source reference 18510

SALOFALK

Suspension / ABBVIE CORPORATION

Canada · Source reference 65824

SALOFALK

Suppository / ABBVIE CORPORATION

Canada · Source reference 18873

SALOFALK (R) 5-ASA ENTERIC COATED TAB- 250MG

Tablet (Enteric-Coated) / AXCAN PHARMA INC

Canada · Source reference 18213

SALOFALK (R) 5-ASA SUPPOSITORIES - 250MG

Suppository / AXCAN PHARMA INC

Canada · Source reference 19524

TEVA-5 ASA

Tablet (Enteric-Coated) / TEVA CANADA LIMITED

Canada · Source reference 106525

ZDS-MESALAMINE SUPPOSITORIES

Suppository / ZYDUS LIFESCIENCES LIMITED

Browse ingredients in Canada